Lupin has said it received approval for its Fluoxetine tablets USP, 10 and 20 mg, from the US FDA to market a generic version of Eli Lilly’s Prozac tablets, 10 and 20 mg. It is indicated in the treatment of major depressive disorder; obsessive compulsive disorder; binge-eating and vomiting behaviours in adult patients with Bulimia Nervosa, and panic disorder, with or without agoraphobia, in adult patients. The stock will be in focus.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.